Suicidal erythrocyte death or eryptosis is characterized by erythrocyte shrinkage, cell membrane blebbing, and cell membrane scrambling with phosphatidylserine translocation to the erythrocyte surface. Triggers of eryptosis include Ca2+ entry, ceramide formation, stimulation of caspases, calpain activation, energy depletion, oxidative stress, and dysregulation of several kinases. Eryptosis is triggered by a wide variety of xenobiotics. It is inhibited by several xenobiotics and endogenous molecules including NO and erythropoietin. The susceptibility of erythrocytes to eryptosis increases with erythrocyte age. Phosphatidylserine exposing erythrocytes adhere to the vascular wall by binding to endothelial CXC-Motiv-Chemokin-16/Scavenger-receptor for phosphatidylserine and oxidized low density lipoprotein (CXCL16). Phosphatidylserine exposing erythrocytes are further engulfed by phagocytosing cells and are thus rapidly cleared from circulating blood. Eryptosis eliminates infected or defective erythrocytes thus counteracting parasitemia in malaria and preventing detrimental hemolysis of defective cells. Excessive eryptosis, however, may lead to anemia and may interfere with microcirculation. Enhanced eryptosis contributes to the pathophysiology of several clinical disorders including metabolic syndrome and diabetes, malignancy, cardiac and renal insufficiency, hemolytic uremic syndrome, sepsis, mycoplasma infection, malaria, iron deficiency, sickle cell anemia, thalassemia, glucose 6-phosphate dehydrogenase deficiency, and Wilson’s disease. Facilitating or inhibiting eryptosis may be a therapeutic option in those disorders.
1. Introduction
The lifespan of circulating erythrocytes is limited by senescence to 100–120 days [1–3]. In senescent erythrocytes hemichromes bind to and cluster the anion exchanger protein band 3 (AE1), leading to attachment of complement C3 fragments and antiband 3 immunoglobulins [4]. Prior to senescence, erythrocytes may enter suicidal death or eryptosis, characterized by erythrocyte shrinkage and cell membrane scrambling with translocation of phosphatidylserine from the inner leaflet of the cell membrane to the erythrocyte surface [5, 6]. Phosphatidylserine avidly binds annexin V, which is thus employed to identify eryptotic cells [5, 6].
The present paper lists triggers and inhibitors or eryptosis, the mechanisms involved in the regulation of eryptosis, and the (patho-) physiological significance of eryptosis. The reader is encouraged to study earlier reviews on further aspects of eryptosis [6–12].
2. Triggers and Inhibitors of Eryptosis
As listed in Table 1, a wide variety of xenobiotics and endogenous small molecules may trigger eryptosis. Moreover, eryptosis is triggered by several other stressors, such as osmotic shock [13], energy depletion [14], oxidative stress [11, 15], or increase of temperature [16]. Eryptosis is inhibited by a variety of xenobiotics (Table 2), by nitric oxide [17], and by erythropoietin [18, 19].
Stimulators of eryptosis.
Stimulators
References
A23187
[9]
Acrolein
[49]
α-lipoic acid
[50]
Aluminium
[18, 51]
Amantadine
[52]
Amiodarone
[53]
Amphotericin B
[54]
Amyloid
[55]
Anandamide
[56]
Anti-A IgG
[57]
Apigenin
[58]
Aristolochic acid
[59]
Arsenic
[60, 61]
Artesunate
[62]
Azathioprine
[63, 64]
Bay 11-7082
[65, 66]
Bay-Y5884
[67]
Beauvericin
[68]
Benzethonium
[69]
betulinic acid
[70]
Bismuth chloride
[71]
Cadmium
[72]
Carbon monoxide
[73]
Carmustine
[74]
Celecoxib
[75]
Ceramide (acylsphingosine)
[76]
Chlorpromazine
[77]
Chromium
[78]
Ciglitazone
[79]
Cisplatin
[80]
Copper
[81]
Cordycepin
[82]
Cryptotanshinone
[83]
Curcurmin
[84]
Cyclosporine
[85, 86]
CD95/Fas/ligand
[87]
Dermaseptin
[88]
Dicoumarol
[89]
Dimethylfumarate
[90]
Enniatin A
[91]
Estramustine
[92]
Ferutinin
[93]
Fluoxetine
[94]
FTY720
[95]
Fumagillin
[96]
Gambogic acid
[97]
Gedunin
[98]
Geldanamycin
[99]
Glycation
[100]
Glycophorin-C
[101]
Gold chloride
[102]
Gold nanorods
[103]
Gossypol
[104]
Granzyme B
[105]
Hemin
[106]
Hexavalent chromium
[107]
Hemolysin
[108]
Honokiol
[109]
Indoxyl sulfate
[110]
IPA3
[111]
Ipratropium bromide
[112]
Lead
[113]
Leukotriene C(4)
[16]
Lipopeptides
[114]
Listeriolysin
[115]
Lithium
[116]
Lumefantrine
[117]
Lysophosphatidic acid
[9]
Mercury
[118]
Methyldopa
[119]
Methylglyoxal
[120]
Miltefosine
[121]
Mitotane
[122]
Mitoxantrone
[123]
Monensin
[124]
Nitazoxanide
[125]
Novobiocin
[126]
Nystatin
[127]
Ochratoxin A
[128]
Oridonin
[129]
Oxysterol
[130]
Paclitaxel
[131, 132]
PAF
[133]
Parthenolide
[65, 66]
Patulin
[134]
Penta-O-galloyl-β-D-glucose
[135]
Peptidoglycan
[136, 137]
Phloretin
[138]
Phorbol-12 myristate-13 acetate
[9]
Phosphate
[139]
Phytic acid
[140]
Plumbagin
[128]
Polyphyllin D
[141]
Probucol
[142]
Prostaglandin E2
[29]
Pyrvinium pamoate
[143, 144]
Radiocontrast agents
[145]
Retinoic acid
[146]
Ribavirin
[147]
Rifampicin
[148]
Rotenone
[149]
Salinomycin
[150]
Selenium (sodium selenite)
[151]
Shikonin
[126]
Silver ions
[152]
Sorafenib
[153]
Sphingomyelinase
[154]
Sphingosine
[155]
Sulindac sulfide
[156]
Sunitinib
[157]
Tannic acid
[94]
Tanshinone IIA
[158]
Thioridazine
[159]
Thrombospondin-1-receptor CD47
[160]
Thymoquinone
[161]
Tin
[162]
Trans-cinnamaldehyde
[163]
Tyrosinase
[164]
Ursolic acid
[165]
Valinomycin
[166]
Sodium vanadate
[167]
Vitamin K(3)
[168]
Withaferin A
[169]
Zearalenone
[170]
Zinc
[171]
Inhibitors of eryptosis.
Inhibitors
References
Adenosine
[172]
Amitriptyline
[173]
Caffeine
[174]
Catecholamines (isoproterenol)
[175]
Chloride
[176]
D4476
[143]
Dibutyryl-cGMP
[17]
Dithiothreitol
[5]
EIPA
[177]
EPO
[19]
Erythropoietin
[19, 178]
Flufenamic acid
[179]
Furosemide
[180]
Glutathione
[38]
7-monohydroxyethylrutoside
[40]
N-acetylcysteine
[18, 20]
Naringin
[181]
NBQX/CNQX
[182]
Niflumic acid
[44]
Nitroprusside (NO-donor)
[17]
NPPB
[44]
Papanonoate (NO-donor)
[17]
P38 Inh III
[183]
Resveratrol
[184]
(R)-DRF053
[143]
Salidroside
[39]
SB203580
[183]
Staurosporine
[14]
Trolox
[31]
Urea
[185]
Vitamin E
[35–37]
Xanthohumol
[186]
Zidovudine
[187]
The susceptibility to stimulation of eryptosis increases with erythrocyte age [20]. The enhanced spontaneous eryptosis of aged erythrocytes is abrogated by the antioxidant N-acetyl-L-cysteine [20]. The mechanism rendering aged erythrocytes particularly vulnerable to eryptosis remained ill-defined [20]. Young erythrocytes are particularly sensitive to suicidal death following decline of erythropoietin, a phenomenon termed neocytolysis [21].
Erythrocytes from newborns are relatively resistant to several triggers of eryptosis but are highly susceptible to eryptosis following oxidative stress [22–24]. The exquisite sensibility of fetal erythrocytes to oxidative stress is presumably instrumental for their removal following birth. The high oxygen affinity of fetal hemoglobin is favourable in the oxygen-depleted intrauterine environment but not after birth [25]. Thus, replacement of fetal erythrocytes by adult erythrocytes is mandatory for adequate oxygen transport after birth.
3. Signaling Regulating Eryptosis
A major trigger of eryptosis is the increase of cytosolic Ca2+ activity (Ca2+i) [6]. The increase of Ca2+i mainly results from Ca2+ entry through Ca2+-permeable unselective cation channels [26, 27], which are permeable to both Na+ and Ca2+ [28]. The channels are activated by prostaglandin E2 (PGE2) [29, 30]. Pharmacological inhibition of cyclooxygenase or phospholipase-A2 disrupts the activation of the channels following osmotic shock [29]. The Ca2+ permeable unselective cation channels are further activated by isosmotic replacement of NaCl with sorbitol [28] and by substitution of extracellular Cl− with gluconate, Br−, I−, or SCN− [28]. They are further activated by oxidative stress or defects of antioxidative defence [31–34], which thus trigger Ca2+ entry and eryptosis [5, 28]. Activation of the channels by oxidative stress is reversed by the reducing agent dithiothreitol [5]. Accordingly, erythrocytes are protected against oxidative stress by several antioxidants including vitamin E [35–37] glutathione [38], salidroside [39], 7-monohydroxyethylrutoside [40], trolox [31], or N-acetylcysteine [18, 20]. The channels involve the transient receptor potential channel TRPC6 [26]. The increase in Ca2+i and eryptosis following Cl− removal were thus blunted in erythrocytes from gene-targeted mice lacking TRPC6 [26].
The increase of Ca2+i following activation of the cation channels is followed by cell shrinkage due to activation of Ca2+-sensitive K+ channels [41, 42], cell membrane hyperpolarization, increase in the electrical driving force for Cl− exit, and the cellular loss of KCl with osmotically obliged water [43]. The Cl− exit requires erythrocyte Cl− channels [44], which are activated by oxidative stress [45, 46]. Cell shrinkage occurs as long as cellular K+ loss through the Ca2+-sensitive K+ channels outcasts the Na+ entry through the unselective cation channels. Sustained exit of K+ and entry of Na+ may lead to dissipation of respective ion gradients across the cell membrane, to cell membrane depolarization, and thus to entry of Cl− and cell swelling [47]. Excessive cell swelling jeopardises the integrity of the cell membrane and may trigger hemolysis [28, 47].
An increase of Ca2+i further stimulates cell membrane scrambling with breakdown of phosphatidylserine asymmetry of the erythrocyte cell membrane and translocation of phosphatidylserine to the erythrocyte surface [48]. Ca2+ sensitivity of the machinery leading to cell membrane scrambling is increased by ceramide [6]. Osmotic shock and a variety of further stimulators of eryptosis activate a phospholipase A2 with following formation platelet-activating factor, which in turn activates a ceramide producing sphingomyelinase [6].
Triggering cell membrane scrambling may involve but does not necessarily require activation of caspases [6, 103, 224], which are expressed in erythrocytes [225, 226], cleave the anion exchanger AE1 [225], and stimulate phosphatidylserine exposure of erythrocytes [227]. Caspase activation participates, for instance, in the triggering of eryptosis by leukotrienes [16] and α-lipoic acid [50]. The caspases are further activated by oxidative stress [228]. Ca2+ entry and Ca2+-dependent cell membrane scrambling do, however, not require activation of caspases [48, 76, 229].
Signaling influencing eryptosis further involves Janus-activated kinase JAK3 [222]. The kinase is phosphorylated at Tyr 980 and thus activated by energy depletion [222]. JAK3 activation contributes to the stimulation of cell membrane scrambling following energy depletion and the effect of energy depletion on eryptosis is blunted by pharmacological or genetic knockout of JAK3 [222].
Eryptosis following energy depletion is inhibited by the energy sensing AMP-activated kinase (AMPK) [27]. Even without induction of energy depletion, eryptosis is increased in AMPKα1-deficient mice [27]. The excessive eryptosis in AMPKα1-deficient mice leads to profound anemia and splenomegaly due to trapping of eryptotic erythrocytes in the spleen [27]. AMPK deficiency is paralleled by downregulation of p21-activated kinase 2 (PAK2) which presumably participates in the inhibition of eryptosis [111].
Pharmacological evidence points to a role of casein kinase 1α (CK1α) in the increase in Ca2+i and subsequent stimulation of eryptosis upon exposure of erythrocytes to oxidative stress or following energy depletion [143]. Pharmacological activation of CK1α opens cation channels and thus triggers Ca2+ influx into erythrocytes [144]. Osmotic shock activates p38 kinase in human erythrocytes [183] and pharmacological inhibition of p38 kinase blunts the eryptosis following osmotic shock [183]. Eryptosis is apparently inhibited by sorafenib- [153] and sunitinib- [157] sensitive kinases.
Eryptosis is further inhibited by cGMP-dependent protein kinase (cGKI) [217]. cGKI deficient mice suffer from severe anemia and splenomegaly due to excessive eryptosis [217]. cGKI deficiency is at least partially effective by increasing Ca2+i [217]. The kinase is stimulated by nitric oxide (NO) [230–233], a powerful inhibitor of eryptosis [17]. NO is stored in erythrocytes and may be released upon deoxygenation of hemoglobin [234–236]. Eryptosis is inhibited by NO-donors such as nitroprusside [17] at concentrations within or even below the range of those effective in nucleated cells [237, 238]. NO is at least partially effective downstream of Ca2+ as it protects against eryptosis induced by the Ca2+ ionophore ionomycin without appreciably affecting the ionomycin-induced increase of Ca2+i. NO blunts apoptosis of nucleated cells in part by caspase inhibition [239, 240]. However, caspases are not required for the stimulation of eryptosis following increase of Ca2+i [6]. Similar to its effect in nucleated cells [241–245] NO increases nitrosylation of enzymes, which are necessary for induction of cell membrane scrambling [17]. Conversely, protein S-nitrosylation is decreased by treatment of erythrocytes with ionomycin. Enzymes affected include the antiapoptotic enzyme thioredoxin, which is activated by S-nitrosylation [17, 242]. As shown in nucleated cells compromised thioredoxin activity enhances oxidative stress [242, 243]. The effect of NO is partially mimicked by dibutyryl-cGMP [17]. In contrast to low concentrations [17], excessive concentrations of the nitroprusside stimulate eryptosis presumably through oxidative stress [246–248]. NO release is particularly fast from HbF, which has thus a particular potency to counteract eryptosis and inducing vasodilation [249, 250]. In sickle cell disease increased levels of antisickling HbF counteract oxidative stress [251] and presumably eryptosis.
Collectively erythrocyte survival and eryptosis are regulated by an amazingly complex cellular machinery involving Ca2+i, ceramide, oxidative stress, caspases, nitroxide, and a variety of kinases. Most triggers of eryptosis are mainly effective by increasing Ca2+i and/or enhancing ceramide abundance in the cell membrane. Unlike in apoptosis of nucleated cells, caspases do not play a dominant role in the triggering of eryptosis. Survival of erythrocytes does require the activity of several kinases including AMPK and cGKI. Activation of other kinases, such as CK1α and JAK3, triggers eryptosis. The phosphorylation targets of the kinases required for the stimulation or inhibition of eryptosis are still ill-defined. Clearly, tremendous additional experimental effort is required for full understanding of the eryptotic machinery.
4. Significance of Eryptosis
Phosphatidylserine exposing erythrocytes are rapidly cleared from circulating blood [190] as phosphatidylserine binds to respective receptors of phagocytosing cells leading to engulfment and degradation of the affected erythrocytes [6]. As long as accelerated loss of eryptotic erythrocytes is matched by an equivalent increase of erythropoiesis, the number of circulating erythrocytes remains unaffected [6]. The enhanced turnover of erythrocytes is then reflected by an increased percentage of reticulocytes [6]. As soon as the loss of erythrocytes by eryptosis outcasts the formation of new erythrocytes, anemia develops [6].
Phosphatidylserine-exposing erythrocytes further adhere to the vascular wall by binding of phosphatidylserine to endothelial CXC-Motiv-Chemokin-16/Scavenger receptor for phosphatidylserine and oxidized low density lipoprotein (CXCL16/SR-PSOX) [252]. Further structures binding phosphatidylserine-exposing erythrocytes include the heparin-binding domain [253] of endothelial or subendothelial thrombospondin-1 (TSP) [254] or endothelial phosphatidylserine receptors [255]. As adherence of eryptotic erythrocytes to endothelial cells is virtually abrogated by silencing of endothelial CXCL16/SRPSO or by coating phosphatidylserine at the erythrocyte surface with annexin V, the erythrocytes bind apparently in large part by interaction of phosphatidylserine with endothelial CXCL16/SRPSO [252]. Phosphatidylserine exposing erythrocytes further adhere to blood platelets [252, 256]. The adherence of phosphatidylserine-exposing erythrocytes to vascular wall and to blood platelets compromises microcirculation [252, 257]. Phosphatidylserine-exposing erythrocytes may further trigger blood clotting and thus foster thrombosis [257].
5. Diseases Associated with Enhanced Eryptosis
Increased eryptosis contributes to the pathophysiology of diverse clinical disorders (Table 3) and is observed in a variety of knockout mice (Table 4). Eryptosis is augmented following dehydration, an effect paralleled by increase of 1,25(OH)2D3 plasma levels [188]. Along those lines, enhanced eryptosis is observed in Klotho deficient mice which suffer from excessive 1,25(OH)2D3 formation [218, 219]. The eryptosis in those mice is blunted by vitamin D deficient diet [218, 219]. Eryptosis is further triggered by severe phosphate depletion [193], an effect presumably due to compromised ATP generation.
cGMP-dependent protein kinase type I (cGKI) deficiency
[217]
AMP-activated protein kinase deficiency
[27]
Klotho deficiency
[218, 219]
EPO excess
[220]
AE1 deficiency
[221]
Reduced eryptosis
PAF receptor deficiency
[133]
Jak3 deficiency
[222]
PDK1 deficiency
[223]
TRPC6 deficiency
[26]
The percentage of phosphatidylserine-exposing erythrocytes is enhanced in iron deficiency which leads to decrease of cell volume and increase of cytosolic Ca2+ concentration [190]. The enhanced Ca2+i results from activation of the Ca2+ permeable unselective cation channels [190] and possibly from increased oxidative stress [258]. The enhanced eryptosis is paralleled by accelerated clearance of iron-deficient erythrocytes, which thus compounds the anemia [190].
Eryptosis is enhanced in malignancy [259]. Little is known about underlying mechanisms. The effect is compounded by cytostatic treatment, as a wide variety of cytostatic drugs do not only trigger apoptosis of tumor cells but as well suicidal death of erythrocytes (Table 1).
The percentage of phosphatidylserine-exposing erythrocytes in circulating blood is increased in diabetic patients [120, 224, 260]. Eryptosis is stimulated by methylglyoxal [120], which accumulates in hyperglycemia [261]. Methylglyoxal is at least partially effective by interference with glycolysis and by decrease of ATP and GSH concentrations [120]. Hyperglycemia imposes oxidative stress [262] with GSH depletion [262], increase of malondialdehyde concentrations [262], increased SOD activity [263], and erythrocyte lipid peroxidation [260]. Eryptosis has further been postulated to be enhanced in metabolic syndrome [191].
Eryptosis is further enhanced in chronic kidney disease (CKD) [19, 196], a condition invariably associated with anemia [264, 265]. The anemia of CKD is commonly attributed to lack of renal erythropoietin release and subsequent impairment of erythropoiesis [266, 267]. CKD is further commonly paralleled by iron deficiency [266, 268–271]. However, CKD leads to enhanced percentage of phosphatidylserine exposing erythrocytes [19, 196, 197] and accelerated clearance of circulating erythrocytes [272]. Accordingly, profound anemia occurs even in patients who are adequately treated with erythropoietin and thus have normal reticulocyte numbers in circulating blood [197]. Erythrocytes from CKD patients are exposed to oxidative stress [273]. The enhanced eryptosis in CKD patients is further partially due to hyperphosphatemia [139] and in part due to accumulation of uremic toxins, such as vanadate [167], acrolein [49], indoxyl sulfate [110], and methylglyoxal [120]. Acrolein and methylglyoxal may be partially effective by depleting the cells from glutathione [274].
Eryptosis is triggered by hemolytic uremic syndrome (HUS), characterized by hemolytic anemia with fragmented erythrocytes, thrombocytopenia, and acute renal failure [198]. The disorder may result from intoxication with bacterial shiga toxin or from complement activation due to lack of complement-inactivating factor H [198]. Plasma from HUS patients triggers in erythrocytes from healthy volunteers phosphatidylserine exposure, cell shrinkage, increase in cytosolic Ca2+ activity, and ceramide formation [198]. The effect of patient plasma on eryptosis is abolished by plasmapheresis or filtration at 30 kDa. Eryptosis is similarly triggered by activated complement [198]. Mechanisms involved include oxidative stress and lipid peroxidation [275]. Both are imposed by neutrophils [276].
Severe eryptosis is observed in sepsis [199]. Again, plasma from septic patients stimulates phosphatidylserine exposure, cell shrinkage, increase in cytosolic Ca2+ activity, and ceramide formation in erythrocytes from healthy individuals [199]. The effect is mimicked by exposure of erythrocytes to supernatant of pathogens and paralleled by enhanced sphingomyelinase activity [199]. Again, sepsis imposes oxidative stress [277], which may participate in the triggering of eryptosis.
Enhanced eryptosis is observed in Wilson’s disease [81], a genetic disorder caused by Cu2+ accumulation due to inactivating mutations of Cu2+-secreting ATP7B [278]. The eryptosis is paralleled by mild anemia [278]. Eryptosis in Wilson’s disease is in large part secondary to activation of acid sphingomyelinase with ceramide formation [81]. Moreover, erythrocytes from patients with Wilson’s disease are exposed to oxidative stress [279] presumably due to copper-related oxidants [280].
A mutation of the anion exchanger AE1 in humans [214] or genetic knockout of the carrier in mice [221] is followed by opening of the Ca2+ permeable unselective cation channels in erythrocytes and thus by accelerated eryptosis. An extremely rare mutation of GLUT1 turns the carrier into a Ca2+ permeable unselective cation channel similarly enhancing eryptosis [215].
The susceptibility to eryptosis is increased in sickle cell anemia, thalassemia, and glucose 6-phosphate dehydrogenase deficiency [203, 281, 282]. Enhanced phosphatidylserine exposure fosters adhesion of the erythrocytes to endothelial cells [283–286]. Adhesion of sickle cells to the pulmonary vascular wall is fostered by activated neutrophils [283]. The binding of sickle cells to endothelial cells is decreased by annexin V indicating that it is largely due to endothelial adhesion of erythrocytic phosphatidylserine [287] but may, in addition, involve very late-activating antigen-4 (VLA-4) and CD36 [288]. HbF counteracts eryptosis and endothelial adhesion of sickle cells to endothelial cells [24, 251, 287, 289, 290]. Expression of HbF could be enhanced by hydroxyurea, which thus decreases sickling and thus vasoocclusive complications [251, 291]. HbF may, however, sensitize erythrocytes to oxidative stress-induced eryptosis (see Section 2), which may, at least in theory, limit the therapeutic benefit of hydroxyurea. Heterozygous carriers of the genetic disorders, such as heterozygous sickle cell carriers (HbA/S), do not spontaneously become suicidal and the respective individuals are virtually healthy [281]. Nevertheless, the erythrocytes are more sensitive to the eryptotic effects of oxidative stress [281].
The malaria pathogen Plasmodium falciparum imposes oxidative stress on the host erythrocytes and thus activates several ion channels in the erythrocyte cell membrane [292], including the oxidant-sensitive Ca2+-permeable erythrocyte cation channels [45, 46, 293]. The channels accomplish uptake of nutrients, Na+ and Ca2+ as well as disposal of waste products, and are thus required for intraerythrocytic survival of Plasmodium falciparum [8, 281, 292–294]. The Ca2+ entry following activation of the Ca2+-permeable cation channels leads, however, to stimulation of eryptosis [32–34] and subsequent clearance of the affected erythrocytes from circulating blood [295]. The pathogen sequesters Ca2+ thus slowing the increase of Ca2+i [296]. The pathogen further digests hemoglobin and exports the respective amino acids [297]. Plasmodium falciparum infection eventually leads to cell membrane scrambling with exposure of phosphatidylserine [105, 294, 298, 299] and subsequent phagocytotic clearance of pathogen-containing erythrocytes [300, 301]. The pathogen may further foster erythrocyte senescence contributing to the clearance of infected cells [301, 302]. Adherence of phosphatidylserine-exposing erythrocytes to endothelial cells further leads to tissue sequestration of Plasmodium-infected cells allowing partial immune evasion of pathogen-containing erythrocytes [303].
Upon infection, eryptosis is accelerated in erythrocytes from heterozygous carriers of the sickle-cell trait (HbA/S), beta-thalassemia-trait, homozygous Hb-C, and G6PD-deficiency thus leading to early clearance of infected erythrocytes, decreased parasitemia, and a relatively mild course of the disease [1, 203–206, 210, 212, 281, 300]. As shown for HbA/S erythrocytes [281], spontaneous eryptosis is in those individuals usually not clinically relevant. Following infection with P. falciparum, however, the formation of PGE2, Ca2+ permeability, phosphatidylserine exposure at the cell surface, and removal by macrophages are all augmented in HbA/S carriers [281]. The accelerated eryptosis in iron deficiency similarly confers some protection against a severe course of malaria [304]. Moreover, parasitemia and clinical course of malaria can be favourably influenced by pharmacological stimulation of eryptosis, for example, by lead [305], chlorpromazine [85], and inhibition of NO synthase by L-NAME [201]. Importantly, the pathogen should be unable to become resistant to therapeutic acceleration of eryptosis, which depends on host cell mechanisms and is thus not at the genetic disposal of the pathogen. Along those lines, the pathogen remained unable to overcome the relative resistance of sickle cell trait carriers to malaria.
6. Conclusions
Similar to apoptosis of nucleated cells, eryptosis is a physiological mechanism eliminating defective erythrocytes in order to prevent hemolysis and subsequent release of hemoglobin into circulating blood. Excessive eryptosis may, however, cause anemia and impede microcirculation. Orchestration of eryptosis involves Ca2+-permeable unselective cation channels, ceramide, caspases, and a variety of kinases including Janus-activated kinase 3, AMP-activated kinase, cGMP-dependent protein kinase, casein kinase 1α, p38 kinase, protein kinase C, and p21-activated kinase 2. The sensitivity to eryptosis is enhanced in aged erythrocytes. Fetal erythrocytes are particularly sensitive to oxidative stress. Eryptosis is triggered by a wide variety of xenobiotics and enhanced eryptosis is observed in several clinical conditions including dehydration, diabetes, cardiac and renal insufficiency, hemolytic uremic syndrome, sepsis, malaria, iron deficiency, sickle cell anemia, thalassemia, glucose 6-phosphate dehydrogenase deficiency, and Wilson’s disease. Drugs and nutrients inhibiting eryptosis may open novel therapeutic options in the treatment of anemia and deranged microcirculation. Eryptosis stimulating xenobiotics may at least in theory accelerate removal of Plasmodium infected erythrocytes and thus favourably influence the clinical course of malaria.
AbbreviationsAE1:
Band 3 or anion exchanger 1
AMPK:
AMP-activated kinase (AMPK)
[Ca2+]i:
Cytosolic Ca2+ concentration
CD36:
Cluster of differentiation 36
cGK:
cGMP-dependent protein kinase
CK1α:
Casein kinase 1α
CXCL16/SR-PSOX:
CXC-Motiv-Chemokin-16/Scavenger receptor for phosphatidylserine and oxidized low density lipoprotein (SR-PSOX)
GSH:
Reduced glutathione
GCLM:
Glutamate cysteine ligase modulator
G6PDH:
Glucose-6-phosphate dehydrogenase
Hb:
Hemoglobin
HUS:
Hemolytic uremic syndrome
JAK3:
Janus-activated kinase JAK3
L-NAME:
L-NG-Nitroarginine Methyl Ester
NADPH:
Nicotinamide adenine dinucleotide phosphate
NO:
Nitric oxide
PAK2:
p21-activated kinase PAK2
PGE2:
Prostaglandin E2
ROS:
Reactive oxygen species
SOD:
Cu, Zn-superoxide dismutase
TRPC6:
Transient receptor potential channel 6
TSP:
Thrombospondin-1
VLA-4:
Very late-activating antigen-4.
Conflict of Interests
The authors declare that no competing financial interests exist. The sponsor(s) had no role in study design, collection, writing, analysis and interpretation of data, or in the decision to submit the paper for publication.
Acknowledgments
The authors acknowledge the meticulous preparation of the paper by Tanja Loch. Research in the authors’ laboratory was supported by the Deutsche Forschungsgemeinschaft.
AreseP.TurriniF.SchwarzerE.Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes2005164–613314610.1159/0000898392-s2.0-27844579180BosmanG. J. C. G. M.WillekensF. L. A.WerreJ. M.Erythrocyte aging: a more than superficial resemblance to apoptosis?2005161–31810.1159/0000877252-s2.0-23944455330KieferC. R.SnyderL. M.Oxidation and erythrocyte senescence20007211311610.1097/00062752-200003000-000072-s2.0-0033957066LutzH. U.Innate immune and non-immune mediators of erythrocyte clearance2004502107116LangF.LangK. S.LangP. A.HuberS. M.WiederT.Mechanisms and significance of eryptosis200687-81183119210.1089/ars.2006.8.11832-s2.0-33746810505LangE.QadriS. M.LangF.Killing me softly—suicidal erythrocyte death20124481236124310.1016/j.biocel.2012.04.0192-s2.0-84861418715ÇimenM. Y. B.Free radical metabolism in human erythrocytes20083901-211110.1016/j.cca.2007.12.0252-s2.0-39649106568FöllerM.BobbalaD.KokaS.HuberS. M.GulbinsE.LangF.Suicide for survival—death of infected erythrocytes as a host mechanism to survive malaria2009243-413314010.1159/0002332382-s2.0-68349127308NguyenD. B.Wagner-BritzL.MaiaS.SteffenP.WagnerC.KaestnerL.BernhardtI.Regulation of phosphatidylserine exposure in red blood cells201128584785610.1159/0003357982-s2.0-83755195384LangF.QadriS. M.Mechanisms and significance of eryptosis, the suicidal death of erythrocytes2012331–312513010.1159/0003341632-s2.0-84856052014LangF.AbedM.LangE.FöllerM.Oxidative stress and suicidal erythrocyte death201421113815310.1089/ars.2013.5747LangF.LangE.FllerM.Physiology and pathophysiology of eryptosis201239530831410.1159/0003425342-s2.0-84866981568LangK. S.DurantonC.PoehlmannH.MyssinaS.BauerC.LangF.WiederT.HuberS. M.Cation channels trigger apoptotic death of erythrocytes200310224925610.1038/sj.cdd.44011442-s2.0-0038702485KlarlB. A.LangP. A.KempeD. S.NiemoellerO. M.AkelA.SobiesiakM.EiseleK.PodolskiM.HuberS. M.WiederT.LangF.Protein kinase C mediates erythrocyte “programmed cell death” following glucose depletion20062901C244C25310.1152/ajpcell.00283.20052-s2.0-33644816186KampD.SiebergT.HaestC. W. M.Inhibition and stimulation of phospholipid scrambling activity. Consequences for lipid asymmetry, echinocytosis, and microvesiculation of erythrocytes200140319438944610.1021/bi01074922-s2.0-0035822663FollerM.MahmudH.GuS.WangK.FlorideE.KucherenkoY.LuikS.LauferS.LangF.Participation of leukotriene C4 in the regulation of suicidal erythrocyte death20096031351432-s2.0-70350236408NicolayJ. P.LiebigG.NiemoellerO. M.KokaS.GhashghaeiniaM.WiederT.HaendelerJ.BusseR.LangF.Inhibition of suicidal erythrocyte death by nitric oxide200845622933052-s2.0-4204908636910.1007/s00424-007-0393-1VotaD. M.CrispR. L.NesseA. B.VittoriD. C.Oxidative stress due to aluminum exposure induces eryptosis which is prevented by erythropoietin201211351581158910.1002/jcb.240262-s2.0-84859064936MyssinaS.HuberS. M.BirkaC.LangP. A.LangK. S.FriedrichB.RislerT.WiederT.LangF.Inhibition of erythrocyte cation channels by erythropoietin200314112750275710.1097/01.asn.0000093253.42641.c12-s2.0-0142213938GhashghaeiniaM.CluitmansJ. C. A.AkelA.DreischerP.ToulanyM.KöberleM.SkabytskaY.SakiM.BiedermannT.DuszenkoM.LangF.WiederT.BosmanG. J. C. G. M.The impact of erythrocyte age on eryptosis2012157560661410.1111/j.1365-2141.2012.09100.x2-s2.0-84860837097RiceL.AlfreyC. P.The negative regulation of red cell mass by neocytolysis: physiologic and pathophysiologic manifestations20051562452502-s2.0-2254447879610.1159/000087234HermleT.ShumilinaE.AttanasioP.AkelA.KempeD. S.LangP. A.PodolskiM.GatzS.BachmannR.BachmannC.AbeleH.HuberS.WiederT.LangF.Decreased cation channel activity and blunted channel-dependent eryptosis in neonatal erythrocytes20062914C710C71710.1152/ajpcell.00631.20052-s2.0-33749346801JainS. K.Presence of phosphatidylserine in the outer membrane bilayer of newborn human erythrocytes1986136391492010.1016/0006-291x(86)90419-52-s2.0-0022458970SettyB. N. Y.KulkarniS.RaoA. K.StuartM. J.Fetal hemoglobin in sickle cell disease: relationship to erythrocyte phosphatidylserine exposure and coagulation activation2000963111911242-s2.0-0034254238BellS. G.An introduction to hemoglobin physiology19991829152-s2.0-0033085191FöllerM.KasinathanR. S.KokaS.LangC.ShumilinaE.BirnbaumerL.LangF.HuberS. M.TRPC6 contributes to the Ca2+ leak of human erythrocytes2008211–318319210.1159/0001137602-s2.0-38349094542FöllerM.SopjaniM.KokaS.GuS.MahmudH.WangK.FlorideE.SchleicherE.SchulzE.MünzelT.LangF.Regulation of erythrocyte survival by AMP-activated protein kinase20092341072108010.1096/fj.08-1217722-s2.0-65349138878DurantonC.HuberS. M.LangF.Oxidation induces a Cl−-dependent cation conductance in human red blood cells2002539384785510.1113/jphysiol.2001.0130402-s2.0-0037088836LangP. A.KempeD. S.MyssinaS.TanneurV.BirkaC.LauferS.LangF.WiederT.HuberS. M.PGE2 in the regulation of programmed erythrocyte death20051254154282-s2.0-1864437553210.1038/sj.cdd.4401561KaestnerL.BernhardtI.Ion channels in the human red blood cell membrane: their further investigation and physiological relevance2002551-2717410.1016/s1567-5394(01)00164-52-s2.0-0036146457FöllerM.HarrisI. S.EliaA.JohnR.LangF.KavanaghT. J.MakT. W.Functional significance of glutamate-cysteine ligase modifier for erythrocyte survival in vitro and in vivo20132010135013582-s2.0-8488380010210.1038/cdd.2013.70BilmenS.AksuT. A.GümüşlüS.KorgunD. K.CanatanD.Antioxidant capacity of G-6-PD-deficient erythrocytes20013031-2838610.1016/S0009-8981(00)00384-32-s2.0-0035142990MavelliI.CirioloM. R.RossiL.MeloniT.ForteleoniG.de FloraA.BenattiU.MorelliA.RotilioG.Favism: a hemolytic disease associated with increased superoxide dismutase and decreased glutathione peroxidase activities in red blood cells19841391131810.1111/j.1432-1033.1984.tb07969.x2-s2.0-0021357602DamonteG.GuidaL.SdraffaA.BenattiU.MelloniE.ForteleoniG.MeloniT.CarafoliE.de FloraA.Mechanisms of perturbation of erythrocyte calcium homeostasis in favism1992131064965810.1016/0143-4160(92)90075-42-s2.0-0026446640GökkuşuC.MostafazadehT.Changes of oxidative stress in various tissues by long-term administration of vitamin E in hypercholesterolemic rats20033281-215516110.1016/S0009-8981(02)00388-12-s2.0-0037306418KobayashiS.MoriyaH.AsoK.OhtakeT.Vitamin E-bonded hemodialyzer improves atherosclerosis associated with a rheological improvement of circulating red blood cells20036351881188710.1046/j.1523-1755.2003.00920.x2-s2.0-0037408287JainS. K.Vitamin E and stabilization of membrane lipid organization in red blood cells with peroxidative damage19834211-12S43S472-s2.0-0020900437DumaswalaU. J.WilsonM. J.WuY. L.WykleJ.ZhuoL.DouglassL. M.DalekeD. L.Glutathione loading prevents free radical injury in red blood cells after storage200033551752910.1080/107157600003010612-s2.0-0034491656QianE. W.GeD. T.KongS.-K.Salidroside protects human erythrocytes against hydrogen peroxide-induced apoptosis201275453153710.1021/np200555s2-s2.0-84860322995de FranceschiL.TurriniF.HonczarenkoM.AyiK.RiveraA.FlemingM. D.LawT.MannuF.KuypersF. A.BastA.van der VijghW. J. F.BrugnaraC.In vivo reduction of erythrocyte oxidant stress in a murine model of β-thalassemia20048911128712982-s2.0-9144261634BookchinR. M.OrtizO. E.LewV. L.Activation of calcium-dependent potassium channels in deoxygenated sickled red cells19872401932002-s2.0-0023063572BrugnaraC.De FranceschiL.AlperS. L.Inhibition of Ca2+-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives199392152052610.1172/jci1165972-s2.0-0027275040LangP. A.KaiserS.MyssinaS.WiederT.LangF.HuberS. M.Role of Ca2+-activated K+ channels in human erythrocyte apoptosis20032856C1553C156010.1152/ajpcell.00186.20032-s2.0-0242426629MyssinaS.LangP. A.KempeD. S.KaiserS.HuberS. M.WiederT.LangF.Cl -channel blockers NPPB and niflumic acid blunt Ca2+-induced erythrocyte ‘apoptosis’2004144–624124810.1159/0000803332-s2.0-4444374080HuberS. M.UhlemannA.-C.GamperN. L.DurantonC.KremsnerP. G.LangF.Plasmodium falciparum activates endogenous Cl− channels of human erythrocytes by membrane oxidation2002211-222302-s2.0-003708059610.1093/emboj/21.1.22TanneurV.DurantonC.BrandV. B.SanduC. D.AkkayaC.KasinathanR. S.GachetC.SluyterR.BardenJ. A.WileyJ. S.LangF.HuberS. M.Purinoceptors are involved in the induction of an osmolyte permeability in malaria-infected and oxidized human erythrocytes200620113313510.1096/fj.04-3371fje2-s2.0-30744437473LangF.BuschG. L.RitterM.VölklH.WaldeggerS.GulbinsE.HäussingerD.Functional significance of cell volume regulatory mechanisms19987812473062-s2.0-0031917467BergC. P.EngelsI. H.RothbartA.LauberK.RenzA.SchlosserS. F.Schulze-OsthoffK.WesselborgS.Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis20018121197120610.1038/sj.cdd.44009052-s2.0-0035678259AhmedM. S. E.LangerH.AbedM.VoelklJ.LangF.The uremic toxin acrolein promotes suicidal erythrocyte death2013372-315816710.1159/0003501412-s2.0-84878060480BhavsarS. K.BobbalaD.XuanN. T.FöllerM.LangF.Stimulation of suicidal erythrocyte death by α-lipoic acid201026685986810.1159/0003239952-s2.0-78651227387NiemoellerO. M.KiedaischV.DreischerP.WiederT.LangF.Stimulation of eryptosis by aluminium ions2006217216817510.1016/j.taap.2006.09.0012-s2.0-33750736970FöllerM.GeigerC.MahmudH.NicolayJ.LangF.Stimulation of suicidal erythrocyte death by amantadine20085811-2131810.1016/j.ejphar.2007.11.0512-s2.0-38549102137NicolayJ. P.BentzenP. J.GhashghaeiniaM.WiederT.LangF.Stimulation of erythrocyte cell membrane scrambling by amiodarone20072061043105010.1159/0001107132-s2.0-35848958618MahmudH.MauroD.QadriS. M.FöllerM.LangF.Triggering of suicidal erythrocyte death by Amphotericin B2009243-426327010.1159/0002332512-s2.0-68349150824NicolayJ. P.GatzS.LiebigG.GulbinsE.LangF.Amyloid induced suicidal erythrocyte death2007191–417518410.1159/0000992052-s2.0-33847035591BentzenP. J.LangF.Effect of anandamide on erythrocyte survival20072061033104210.1159/0001107142-s2.0-35848957293AttanasioP.ShumilinaE.HermleT.KiedaischV.LangP. A.HuberS. M.WiederT.LangF.Stimulation of eryptosis by anti-A IgG antibodies200720559160010.1159/0001075422-s2.0-34548367512ZbidahM.LupescuA.JilaniK.FajolA.MichaelD.QadriS. M.LangF.Apigenin-induced suicidal erythrocyte death201260153353810.1021/jf204107f2-s2.0-84855777183MalikA.BissingerR.CalabròS.FaggioC.JilaniK.LangF.Aristolochic acid induced suicidal erythrocyte death201439540841910.1159/000368454BiswasD.BanerjeeM.SenG.DasJ. K.BanerjeeA.SauT. J.PanditS.GiriA. K.BiswasT.Mechanism of erythrocyte death in human population exposed to arsenic through drinking water2008230157662-s2.0-4464910759210.1016/j.taap.2008.02.003MahmudH.FöllerM.LangF.Arsenic-induced suicidal erythrocyte death200983210711310.1007/s00204-008-0338-22-s2.0-60449092620AlzoubiK.CalabròS.BissingerR.AbedM.FaggioC.LangF.Stimulation of suicidal erythrocyte death by artesunate20143462232224410.1159/000369666BobbalaD.KokaS.GeigerC.FöllerM.HuberS. M.LangF.Azathioprine favourably influences the course of malaria200981, article 1022-s2.0-6765067507110.1186/1475-2875-8-102GeigerC.FöllerM.HerrlingerK. R.LangF.Azathioprine-induced suicidal erythrocyte death20081481027103210.1002/ibd.204332-s2.0-49749144433GhashghaeiniaM.CluitmansJ. C.ToulanyM.SakiM.KöberleM.LangE.DreischerP.BiedermannT.DuszenkoM.LangF.BosmanG. J.WiederT.Age sensitivity of NFκB abundance and programmed cell death in erythrocytes induced by NFκB inhibitors201332480181310.1159/0003544812-s2.0-84888182490GhashghaeiniaM.ToulanyM.SakiM.BobbalaD.FehrenbacherB.RupecR.RodemannH. P.GhoreschiK.RöckenM.SchallerM.LangF.WiederT.The NFκB pathway inhibitors bay 11-7082 and parthenolide induce programmed cell death in anucleated erythrocytes2011271455410.1159/0003252042-s2.0-79951601376ShumilinaE.KiedaischV.AkkelA.LangP.HermleT.KempeD.HuberS.WiederT.LauferS.LangF.Stimulation of suicidal erythrocyte death by lipoxygenase inhibitor Bay-Y58842006184-523324210.1159/0000976702-s2.0-33845650237QadriS. M.KucherenkoY.LangF.Beauvericin induced erythrocyte cell membrane scrambling2011283124312-s2.0-7995308942610.1016/j.tox.2011.01.023LangE.JilaniK.ZelenakC.PashamV.BobbalaD.QadriS. M.LangF.Stimulation of suicidal erythrocyte death by benzethonium201128234735410.1159/0003317512-s2.0-80052100590GaoM.LauP. M.KongS. K.Mitochondrial toxin betulinic acid induces in vitro eryptosis in human red blood cells through membrane permeabilization201488375576810.1007/s00204-013-1162-x2-s2.0-84896695556BraunM.FöllerM.GulbinsE.LangF.Eryptosis triggered by bismuth200922345346010.1007/s10534-008-9180-52-s2.0-67349225445SopjaniM.FöllerM.DreischerP.LangF.Stimulation of eryptosis by cadmium ions2008221–424525210.1159/0001498022-s2.0-51149106153LangE.QadriS. M.JilaniK.ZelenakC.LupescuA.SchleicherE.LangF.Carbon monoxide-sensitive apoptotic death of erythrocytes2012111534835510.1111/j.1742-7843.2012.00915.x2-s2.0-84867649419JilaniK.LangF.Carmustine-induced phosphatidylserine translocation in the erythrocyte membrane20135470371610.3390/toxins50407032-s2.0-84877270091LupescuA.BissingerR.JilaniK.LangF.Triggering of suicidal erythrocyte death by celecoxib201359154315542-s2.0-8488416214510.3390/toxins5091543LangK. S.MyssinaS.BrandV.SanduC.LangP. A.BerchtoldS.HuberS. M.LangF.WiederT.Involvement of ceramide in hyperosmotic shock-induced death of erythrocytes200411223124310.1038/sj.cdd.44013112-s2.0-0742324394AkelA.HermleT.NiemoellerO. M.KempeD. S.LangP. A.AttanasioP.PodolskiM.WiederT.LangF.Stimulation of erythrocyte phosphatidylserine exposure by chlorpromazine20065321-2111710.1016/j.ejphar.2005.12.0372-s2.0-33644510094LupescuA.JilaniK.ZelenakC.ZbidahM.QadriS. M.LangF.Hexavalent chromium-induced erythrocyte membrane phospholipid asymmetry201225230931810.1007/s10534-011-9507-52-s2.0-84862553285NiemoellerO. M.MahmudH.FöllerM.WiederT.LangF.Ciglitazone and 15d-PGJ2 induced suicidal erythrocyte death2008221–423724410.1159/0001498012-s2.0-51149118903MahmudH.FöllerM.LangF.Suicidal erythrocyte death triggered by cisplatin20082491404410.1016/j.tox.2008.04.0032-s2.0-44649114537LangP. A.SchenckM.NicolayJ. P.BeckerJ. U.KempeD. S.LupescuA.KokaS.EiseleK.KlarlB. A.RübbenH.SchmidK. W.MannK.HildenbrandS.HefterH.HuberS. M.WiederT.ErhardtA.HäussingerD.GulbinsE.LangF.Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide200713216417010.1038/nm15392-s2.0-33846985938LuiJ. C. K.WongJ. W. Y.SuenY. K.KwokT. T.FungK. P.KongS. K.Cordycepin induced eryptosis in mouse erythrocytes through a Ca2+-dependent pathway without caspase-3 activation2007811285986510.1007/s00204-007-0214-52-s2.0-36649034641BissingerR.LupescuA.ZelenakC.JilaniK.LangF.Stimulation of eryptosis by cryptotanshinone201434243244210.1159/000363012BentzenP. J.LangE.LangF.Curcumin induced suicidal erythrocyte death2007191–415316410.1159/0000992032-s2.0-33847044446BobbalaD.KokaS.LangC.BoiniK. M.HuberS. M.LangF.Effect of cyclosporine on parasitemia and survival of Plasmodium berghei infected mice2008376349449810.1016/j.bbrc.2008.09.0052-s2.0-53149096132NiemoellerO. M.AkelA.LangP. A.AttanasioP.KempeD. S.HermleT.SobiesiakM.WiederT.LangF.Induction of eryptosis by cyclosporine20063741414910.1007/s00210-006-0099-5MandalD.MazumderA.DasP.KunduM.BasuJ.Fas-, caspase 8-, and caspase 3-dependent signaling regulates the activity of the aminophospholipid translocase and phosphatidylserine externalization in human erythrocytes200528047394603946710.1074/jbc.M5069282002-s2.0-28244434797AbedM.ZoubiK. A.TheurerM.LangF.Effect of dermaseptin on erythrocytes2013113534735210.1111/bcpt.120962-s2.0-84885468506QadriS. M.KucherenkoY.ZelenakC.JilaniK.LangE.LangF.Dicoumarol activates Ca2+-permeable cation channels triggering erythrocyte cell membrane scrambling201128585786410.1159/0003358002-s2.0-83755178192GhashghaeiniaM.BobbalaD.WiederT.KokaS.BrückJ.FehrenbacherB.RöckenM.SchallerM.LangF.GhoreschiK.Targeting glutathione by dimethylfumarate protects against experimental malaria by enhancing erythrocyte cell membrane scrambling20102994C791C80410.1152/ajpcell.00014.20102-s2.0-77957668709JilaniK.QadriS. M.LangE.ZelenakC.RotteA.BobbalaD.LangF.Stimulation of erythrocyte phospholipid scrambling by enniatin A201155supplement 2S294S30210.1002/mnfr.2011001562-s2.0-80053264829BissingerR.ModicanoP.FrauenfeldL.LangE.JacobiJ.FaggioC.LangF.Estramustine-induced suicidal erythrocyte death20133251426143610.1159/0003565802-s2.0-84890680851GaoM.WongS. Y.LauP. M.KongS. K.Ferutinin induces in vitro eryptosis/erythroptosis in human erythrocytes through membrane permeabilization and calcium influx20132681218122810.1021/tx400127w2-s2.0-84882640853JilaniK.EnkelS.BissingerR.AlmilajiA.AbedM.LangF.Fluoxetine induced suicidal erythrocyte death2013571230124310.3390/toxins50712302-s2.0-84880481609EberhardM.FerlinzK.AlizziK.CacciatoP. M.FaggioC.FöllerM.LangF.FTY720-induced suicidal erythrocyte death2010264-57617662-s2.0-7814944208110.1159/000322343ZbidahM.LupescuA.JilaniK.LangF.Stimulation of suicidal erythrocyte death by fumagillin201311253463512-s2.0-8487642286410.1111/bcpt.12033LupescuA.JilaniK.ZelenakC.ZbidahM.ShaikN.LangF.Induction of programmed erythrocyte death by gambogic acid201230242843810.1159/0003390362-s2.0-84864225407LupescuA.BissingerR.WarsiJ.JilaniK.LangF.Stimulation of erythrocyte cell membrane scrambling by gedunin20143361838184810.1159/000362962JilaniK.QadriS. M.LangF.Geldanamycin-induced phosphatidylserine translocation in the erythrocyte membrane2013326160016092-s2.0-84893057981KucherenkoY. V.BhavsarS. K.GrischenkoV. I.FischerU. R.HuberS. M.LangF.Increased cation conductance in human erythrocytes artificially aged by glycation2010235317718910.1007/s00232-010-9265-22-s2.0-77954425846HeadD. J.LeeZ. E.PooleJ.AventN. D.Expression of phosphatidylserine (PS) on wild-type and Gerbich variant erythrocytes following glycophorin-C (GPC) ligation2005129113013710.1111/j.1365-2141.2005.05407.x2-s2.0-17144395152SopjaniM.FöllerM.LangF.Gold stimulates Ca2+ entry into and subsequent suicidal death of erythrocytes20082442-32712792-s2.0-3874911370810.1016/j.tox.2007.12.001LauI. P.ChenH.WangJ.OngH. C.LeungK. C.-F.HoH. P.KongS. K.In vitro effect of CTAB-and PEG-coated gold nanorods on the induction of eryptosis/erythroptosis in human erythrocytes2012688478562-s2.0-8486901386610.3109/17435390.2011.625132ZbidahM.LupescuA.ShaikN.LangF.Gossypol-induced suicidal erythrocyte death20123022-310110510.1016/j.tox.2012.09.0102-s2.0-84868496151BöttgerE.MulthoffG.KunJ. F. J.EsenM.Plasmodium falciparum-infected erythrocytes induce granzyme B by NK cells through expression of host-Hsp70201273e3377410.1371/journal.pone.00337742-s2.0-84858211907GatidisS.FöllerM.LangF.Hemin-induced suicidal erythrocyte death200988872172610.1007/s00277-009-0697-72-s2.0-67649401770ZhangR.XiangY.RanQ.DengX.XiaoY.XiangL.LiZ.Involvement of calcium, reactive oxygen species, and ATP in hexavalent chromium-induced damage in red blood cells20143451780179110.1159/000366378LangP. A.KaiserS.MyssinaS.BirkaC.WeinstockC.NorthoffH.WiederT.LangF.HuberS. M.Effect of Vibrio parahaemolyticus haemolysin on human erythrocytes2004643914002-s2.0-164229417210.1111/j.1462-5822.2004.00369.xZbidahM.LupescuA.HerrmannT.YangW.FollerM.JilaniK.LangF.Effect of honokiol on erythrocytes20132761737174510.1016/j.tiv.2013.05.0032-s2.0-84878771741AhmedM. S. E.AbedM.VoelklJ.LangF.Triggering of suicidal erythrocyte death by uremic toxin indoxyl sulfate201314, article 24410.1186/1471-2369-14-2442-s2.0-84886744408ZelenakC.FöllerM.VelicA.KrugK.QadriS. M.ViolletB.LangF.MacEkB.Proteome analysis of erythrocytes lacking AMP-activated protein kinase reveals a role of PAK2 kinase in eryptosis20111041690169710.1021/pr101004j2-s2.0-79953715199ShaikN.AlhouraniE.BoscA.LiuG.TowhidS.LupescuA.LangF.Stimulation of suicidal erythrocyte death by ipratropium bromide20123061517152510.1159/0003433392-s2.0-84870746254KempeD. S.LangP. A.EiseleK.KlarlB. A.WiederT.HuberS. M.DurantonC.LangF.Stimulation of erythrocyte phosphatidylserine exposure by lead ions20052882C396C40210.1152/ajpcell.00115.20042-s2.0-12144255585WangK.MahmudH.FöllerM.BiswasR.LangK. S.BohnE.GötzF.LangF.Lipopeptides in the triggering of erythrocyte cell membrane scrambling2008225-638138610.1159/0001871162-s2.0-57649231750FöllerM.ShumilinaE.LamR. S.MohamedW.KasinathanR. S.HuberS. M.ChakrabortyT.LangF.Induction of suicidal erythrocyte death by listeriolysin from Listeria monocytogenes20072061051106010.1159/0001107152-s2.0-35848952556NicolayJ. P.GatzS.LangF.LangU. E.Lithium-induced suicidal erythrocyte death201024101533153910.1177/02698811091026312-s2.0-77958002820AlzoubiK.AlktifanB.OswaldG.FezaiM.AbedM.LangF.Breakdown of phosphatidylserine asymmetry following treatment of erythrocytes with lumefantrine2014626506642-s2.0-8489463686310.3390/toxins6020650EiseleK.LangP. A.KempeD. S.KlarlB. A.NiemöllerO.WiederT.HuberS. M.DurantonC.LangF.Stimulation of erythrocyte phosphatidylserine exposure by mercury ions20062101-211612210.1016/j.taap.2005.07.0222-s2.0-29044436393MahmudH.FöllerM.LangF.Stimulation of erythrocyte cell membrane scrambling by methyldopa20083152993062-s2.0-5084910882810.1159/000153250NicolayJ. P.SchneiderJ.NiemoellerO. M.ArtuncF.Portero-OtinM.HaikG.Jr.ThornalleyP.SchleicherE.WiederT.LangF.Stimulation of suicidal erythrocyte death by methylglyoxal2006184-522323210.1159/0000976692-s2.0-33845602187MunozC.AlzoubiK.JacobiJ.AbedM.LangF.Effect of miltefosine on erythrocytes2013276191319192-s2.0-8488062840110.1016/j.tiv.2013.06.010JacobiJ.LangE.BissingerR.FrauenfeldL.ModicanoP.FaggioC.AbedM.LangF.Stimulation of erythrocyte cell membrane scrambling by mitotane20143351516152610.1159/0003587152-s2.0-84901353440ArnoldM.BissingerR.LangF.Mitoxantrone-induced suicidal erythrocyte death20143451756176710.1159/000366376BhavsarS. K.EberhardM.BobbalaD.LangF.Monensin induced suicidal erythrocyte death201025674575210.1159/0003150942-s2.0-77952997802ArnoldM.LangE.ModicanoP.BissingerR.FaggioC.AbedM.LangF.Effect of nitazoxanide on erythrocytes201411454214262-s2.0-8489796313210.1111/bcpt.12171LupescuA.BissingerR.HerrmannT.OswaldG.JilaniK.LangF.Induction of suicidal erythrocyte death by novobiocin201433367068010.1159/0003586432-s2.0-84895932369MalikA.BissingerR.JilaniK.LangF.Stimulation of erythrocyte cell membrane scrambling by nystatin20151161475210.1111/bcpt.12279JilaniK.LupescuA.ZbidahM.AbedM.ShaikN.LangF.Enhanced apoptotic death of erythrocytes induced by the mycotoxin ochratoxin A201236110711810.1159/0003414882-s2.0-84867690450JilaniK.QadriS. M.ZelenakC.LangF.Stimulation of suicidal erythrocyte death by oridonin20115111-2142010.1016/j.abb.2011.05.0012-s2.0-80955180550TesoriereL.AttanzioA.AllegraM.CillaA.GentileC.LivreaM. A.Oxysterol mixture in hypercholesterolemia-relevant proportion causes oxidative stress-dependent eryptosis20143441075108910.1159/000366322KokaS.BobbalaD.LangC.BoiniK. M.HuberS. M.LangF.Influence of paclitaxel on parasitemia and survival of Plasmodium berghei infected mice2009231–319119810.1159/0002041072-s2.0-60549101348LangP. A.HuoberJ.BachmannC.KempeD. S.SobiesiakM.AkelA.NiemoellerO. M.DreischerP.EiseleK.KlarlB. A.GulbinsE.LangF.WiederT.Stimulation of erythrocyte phosphatidylserine exposure by paclitaxel2006181–31511542-s2.0-3374736396810.1159/000095190LangP. A.KempeD. S.TanneurV.EiseleK.KlarlB. A.MyssinaS.JendrossekV.IshiiS.ShimizuT.WaidmannM.HesslerG.HuberS. M.LangF.WiederT.Stimulation of erythrocyte ceramide formation by platelet-activating factor200511861233124310.1242/jcs.017302-s2.0-20244368666LupescuA.JilaniK.ZbidahM.LangF.Patulin-induced suicidal erythrocyte death201332229129910.1159/0003544372-s2.0-84885611389AlzoubiK.HonischS.AbedM.LangF.Triggering of suicidal erythrocyte death by penta-O-galloyl-beta-D-glucose20146154652-s2.0-84891361707AbedM.TowhidS. T.PakladokT.AlesutanI.GötzF.GulbinsE.LangF.Effect of bacterial peptidoglycan on erythrocyte death and adhesion to endothelial cells2013303418218910.1016/j.ijmm.2013.01.0042-s2.0-84877140759FöllerM.BiswasR.MahmudH.AkelA.ShumilinaE.WiederT.GoetzF.LangF.Effect of peptidoglycans on erythrocyte survival20092991758510.1016/j.ijmm.2008.05.0122-s2.0-56949102503BissingerR.FischerS.JilaniK.LangF.Stimulation of erythrocyte death by phloretin20143462256226510.1159/000369668VoelklJ.AlzoubiK.MamarA.-K.AhmedM. S. E.AbedM.LangF.Stimulation of suicidal erythrocyte death by increased extracellular phosphate concentrations201438142512-s2.0-8489566535810.1159/000355752EberhardM.FöllerM.LangF.Effect of phytic acid on suicidal erythrocyte death20105832028203310.1021/jf903666b2-s2.0-76449121249GaoM.CheungK. L.LauI. P.YuW. S.FungK. P.YuB.LooJ. F.KongS. K.Polyphyllin D induces apoptosis in human erythrocytes through Ca2+ rise and membrane permeabilization201286574175210.1007/s00204-012-0808-42-s2.0-84862871418ShaikN.LupescuA.LangF.Inhibition of suicidal erythrocyte death by probucol201361212012610.1097/FJC.0b013e3182798abc2-s2.0-84873408200ZelenakC.EberhardM.JilaniK.QadriS. M.MacEkB.LangF.Protein kinase CK1α regulates erythrocyte survival2012291-21711802-s2.0-8485987158110.1159/000337598KucherenkoY.ZelenakC.EberhardM.QadriS. M.LangF.Effect of casein kinase 1alpha activator pyrvinium pamoate on erythrocyte ion channels201230240741710.1159/0003390342-s2.0-84864183630FöllerM.SopjaniM.SchlemmerH. P.ClaussenC. D.LangF.Triggering of suicidal erythrocyte death by radiocontrast agents200939757658310.1111/j.1365-2362.2009.02140.x2-s2.0-66849087366NiemoellerO. M.FöllerM.LangC.HuberS. M.LangF.Retinoic acid induced suicidal erythrocyte death2008211–319320210.1159/0001137612-s2.0-38349137747OswaldG.AlzoubiK.AbedM.LangF.Stimulation of suicidal erythrocyte death by ribavirin2014114431131710.1111/bcpt.12165AbedM.TowhidS. T.ShaikN.LangF.Stimulation of suicidal death of erythrocytes by rifampicin20123022-312312810.1016/j.tox.2012.10.0062-s2.0-84868445257LupescuA.JilaniK.ZbidahM.LangF.Induction of apoptotic erythrocyte death by rotenone2012300313213710.1016/j.tox.2012.06.0072-s2.0-84864070776BissingerR.MalikA.JilaniK.LangF.Triggering of erythrocyte cell membrane scrambling by salinomycin2014115539640210.1111/bcpt.12250SopjaniM.FöllerM.GulbinsE.LangF.Suicidal death of erythrocytes due to selenium-compounds2008225-638739410.1159/0001854522-s2.0-57649166135SopjaniM.FöllerM.HaendelerJ.GötzF.LangF.Silver ion-induced suicidal erythrocyte death200929653153610.1002/jat.14382-s2.0-68949116193LupescuA.ShaikN.JilaniK.ZelenakC.LangE.PashamV.ZbidahM.PlateA.BitzerM.FöllerM.QadriS. M.LangF.Enhanced erythrocyte membrane exposure of phosphatidylserine following sorafenib treatment: an in vivo and in vitro study201230487688810.1159/0003414652-s2.0-84865058970AbedM.TowhidS. T.MiaS.PakladokT.AlesutanI.BorstO.GawazM.GulbinsE.LangF.Sphingomyelinase-induced adhesion of eryptotic erythrocytes to endothelial cells20123039C991C99910.1152/ajpcell.00239.20122-s2.0-84868321858QadriS. M.BauerJ.ZelenakC.MahmudH.KucherenkoY.LeeS. H.FerlinzK.LangF.Sphingosine but not sphingosine-1-phosphate stimulates suicidal erythrocyte death201128233934610.1159/0003317502-s2.0-80052077564ZbidahM.LupescuA.YangW.BoscA.JilaniK.ShaikN.LangF.Sulindac sulfde—induced stimulation of eryptosis20123041072108210.1159/0003414832-s2.0-84873199275ShaikN.LupescuA.LangF.Sunitinib-sensitive suicidal erythrocyte death201230351252210.1159/0003414342-s2.0-84863875401ZelenakC.PashamV.JilaniK.TripodiP. M.RosaclerioL.PathareG.LupescuA.FaggioC.QadriS. M.LangF.Tanshinone IIA stimulates erythrocyte phosphatidylserine exposure201230128229410.1159/0003390642-s2.0-84863475409LangE.ModicanoP.ArnoldM.BissingerR.FaggioC.AbedM.LangF.Effect of thioridazine on erythrocytes20135101918193110.3390/toxins51019182-s2.0-84891366836HeadD. J.LeeZ. E.SwallahM. M.AventN. D.Ligation of CD47 mediates phosphatidylserine expression on erythrocytes and a concomitant loss of viability in vitro200513057887902-s2.0-2724444948510.1111/j.1365-2141.2005.05668.xQadriS. M.MahmudH.FöllerM.LangF.Thymoquinone-induced suicidal erythrocyte death20094771545154910.1016/j.fct.2009.03.0372-s2.0-67349254977NguyenT. T.FöllerM.LangF.Tin triggers suicidal death of erythrocytes2009291798310.1002/jat.13902-s2.0-58149458011TheurerM.ShaikN.LangF.Stimulation of suicidal erythrocyte death by trans-cinnamaldehyde201320121119112310.1016/j.phymed.2013.05.0062-s2.0-84883165712FrauenfeldL.AlzoubiK.AbedM.LangF.Stimulation of erythrocyte cell membrane scrambling by mushroom tyrosinase201463109611082-s2.0-8489789720310.3390/toxins6031096JilaniK.AbedM.ZelenakC.LangE.QadriS. M.LangF.Triggering of erythrocyte cell membrane scrambling by ursolic acid20117410218121862-s2.0-8005509946310.1021/np2005133SchneiderJ.NicolayJ. P.FöllerM.WiederT.LangF.Suicidal erythrocyte death following cellular K+ loss2007201–4354410.1159/0001041512-s2.0-34250773866FöllerM.SopjaniM.MahmudH.LangF.Vanadate-induced suicidal erythrocyte death2008312879310.1159/0001197042-s2.0-43049129678QadriS. M.EberhardM.MahmudH.FöllerM.LangF.Stimulation of ceramide formation and suicidal erythrocyte death by vitamin K3 (menadione)20096231–3101310.1016/j.ejphar.2009.09.0112-s2.0-70350211425JilaniK.LupescuA.ZbidahM.ShaikN.LangF.Withaferin A-stimulated Ca2+ entry, ceramide formation and suicidal death of erythrocytes201327152582-s2.0-8486939680810.1016/j.tiv.2012.09.004JilaniK.LangF.Ca2+-dependent suicidal erythrocyte death following zearalenone exposure20138710182118282-s2.0-8488542859710.1007/s00204-013-1037-1KiedaischV.AkelA.NiemoellerO. M.WiederT.LangF.Zinc-induced suicidal erythrocyte death2008875153015342-s2.0-43549113610NiemoellerO. M.BentzenP. J.LangE.LangF.Adenosine protects against suicidal erythrocyte death2007454342743910.1007/s00424-007-0218-22-s2.0-34248344527BrandV.KokaS.LangC.JendrossekV.HuberS. M.GulbinsE.LangF.Influence of amitriptyline on eryptosis, parasitemia and survival of Plasmodium berghei-infected mice2008225-640541210.1159/0001854822-s2.0-57649200114FlorideE.FöllerM.RitterM.LangF.Caffeine inhibits suicidal erythrocyte death2008221–425326010.1159/0001498032-s2.0-51149088149LangP. A.KempeD. S.AkelA.KlarlB. A.EiseleK.PodolskiM.HermleT.NiemoellerO. M.AttanasioP.HuberS. M.WiederT.LangF.DurantonC.Inhibition of erythrocyte 'apoptosis' by catecholamines2005372322823510.1007/s00210-005-0009-22-s2.0-27944451517HuberS. M.GamperN.LangF.Chloride conductance and volume-regulatory nonselective cation conductance in human red blood cell ghosts2001441455155810.1007/s0042400004562-s2.0-0035141179LangK. S.MyssinaS.TanneurV.WiederT.HuberS. M.LangF.DurantonC.Inhibition of erythrocyte cation channels and apoptosis by ethylisopropylamiloride2003367439139610.1007/s00210-003-0701-z2-s2.0-0038408717VotaD. M.MaltaneriR. E.WenkerS. D.NesseA. B.VittoriD. C.Differential erythropoietin action upon cells induced to eryptosis by different agents201365214515710.1007/s12013-012-9408-42-s2.0-84874232618KasinathanR. S.FöllerM.KokaS.HuberS. M.LangF.Inhibition of eryptosis and intraerythrocytic growth of Plasmodium falciparum by flufenamic acid2007374425526410.1007/s00210-006-0122-x2-s2.0-33846178289KucherenkoY. V.LangF.Inhibitory effect of furosemide on non-selective voltage-independent cation channels in human erythrocytes201230486387510.1159/0003414642-s2.0-84865056373ShaikN.ZbidahM.LangF.Inhibition of Ca2+ entry and suicidal erythrocyte death by naringin201230367868610.1159/0003414482-s2.0-84864397354FöllerM.MahmudH.GuS.KucherenkoY.GehringE.-M.ShumilinaE.FlorideE.SprengelR.LangF.Modulation of suicidal erythrocyte cation channels by an AMPA antagonist2009139368036862-s2.0-7744915785610.1111/j.1582-4934.2009.00745.xGatidisS.ZelenakC.FajolA.LangE.JilaniK.MichaelD.QadriS. M.LangF.P38 MAPK activation and function following osmotic shock of erythrocytes20112861279128610.1159/0003358592-s2.0-83755206903QadriS. M.FöllerM.LangF.Inhibition of suicidal erythrocyte death by resveratrol2009851-2333810.1016/j.lfs.2009.04.0152-s2.0-67349150481LangK. S.MyssinaS.LangP. A.TanneurV.KempeD. S.MackA. F.HuberS. M.WiederT.LangF.DurantonC.Inhibition of erythrocyte phosphatidylserine exposure by urea and Cl−20042866F1046F105310.1152/ajprenal.00263.20032-s2.0-2442659061QadriS. M.MahmudH.FöllerM.LangF.Inhibition of suicidal erythrocyte death by xanthohumol200957167591759510.1021/jf900773w2-s2.0-70349204178KucherenkoY.GeigerC.ShumilinaE.FöllerM.LangF.Inhibition of cation channels and suicidal death of human erythrocytes by zidovudine20082531–3626910.1016/j.tox.2008.08.0122-s2.0-55049098681AbedM.FegerM.AlzoubiK.PakladokT.FrauenfeldL.GeigerC.TowhidS. T.LangF.Sensitization of erythrocytes to suicidal erythrocyte death following water deprivation201337656757810.1159/0003557372-s2.0-84891069635WeissE.CytlakU. M.ReesD. C.OseiA.GibsonJ. S.Deoxygenation-induced and Ca2+ dependent phosphatidylserine externalisation in red blood cells from normal individuals and sickle cell patients2012511515610.1016/j.ceca.2011.10.0052-s2.0-84856108016KempeD. S.LangP. A.DurantonC.AkelA.LangK. S.HuberS. M.WiederT.LangF.Enhanced programmed cell death of iron-deficient erythrocytes200620236837010.1096/fj.05-4872fje2-s2.0-33644891025ZappullaD.Environmental stress, erythrocyte dysfunctions, inflammation, and the metabolic syndrome: adaptations to CO2 increases?200831303410.1111/j.1559-4572.2008.07263.x2-s2.0-45149094904FıratU.KayaS.ÇimA.BüyükbayramH.GökalpO.DalM. S.TamerM. N.Increased caspase-3 immunoreactivity of erythrocytes in STZ diabetic rats20122012431638410.1155/2012/316384BirkaC.LangP. A.KempeD. S.HoeflingL.TanneurV.DurantonC.NammiS.HenkeG.MyssinaS.KrikovM.HuberS. M.WiederT.LangF.Enhanced susceptibility to erythrocyte ‘apoptosis’ following phosphate depletion200444854714772-s2.0-4344698212BanerjeeD.SahaS.BasuS.ChakrabartiA.Porous red cell ultrastructure and loss of membrane asymmetry in a novel case of hemolytic anemia200881539940210.1111/j.1600-0609.2008.01153.x2-s2.0-54249133510MahmudH.RuifrokW. P. T.WestenbrinkB. D.CannonM. V.Vreeswijk-BaudoinI.Van GilstW. H.SilljéH. H. W.De BoerR. A.Suicidal erythrocyte death, eryptosis, as a novel mechanism in heart failure-associated anaemia201398137462-s2.0-8487516229810.1093/cvr/cvt010Polak-JonkiszD.PurzycL.Ca2+ influx versus efflux during eryptosis in uremic erythrocytes2012343-420921010.1159/000341627AbedM.ArtuncF.AlzoubiK.HonischS.BaumannD.FöllerM.LangF.Suicidal erythrocyte death in end-stage renal disease20149288718792-s2.0-8490158352810.1007/s00109-014-1151-4LangP. A.BeringerO.NicolayJ. P.AmonO.KempeD. S.HermleT.AttanasioP.AkelA.SchäferR.FriedrichB.RislerT.BaurM.OlbrichtC. J.ZimmerhacklL. B.ZipfelP. F.WiederT.LangF.Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome200684537838810.1007/s00109-006-0058-02-s2.0-33646337960KempeD. S.AkelA.LangP. A.HermleT.BiswasR.MuresanuJ.FriedrichB.DreischerP.WolzC.SchumacherU.PeschelA.GötzF.DöringG.WiederT.GulbinsE.LangF.Suicidal erythrocyte death in sepsis200785326927710.1007/s00109-006-0123-82-s2.0-33847129228FelderK. M.HoelzleK.RitzmannM.KilchlingT.SchieleD.HeinritziK.GroebelK.HoelzleL. E.Hemotrophic mycoplasmas induce programmed cell death in red blood cells20112755575642-s2.0-7995946234010.1159/000329957KokaS.LangC.NiemoellerO. M.BoiniK. M.NicolayJ. P.HuberS. M.LangF.Influence of NO synthase inhibitor L-NAME on parasitemia and survival of Plasmodium berghei infected mice2008215-64814882-s2.0-4294911158810.1159/000129641TotinoP. R. R.Daniel-RibeiroC. T.Ferreira-da-CruM. D. F.Refractoriness of eryptotic red blood cells to plasmodium falciparum infection: a putative host defense mechanism limiting parasitaemia2011610e2657510.1371/journal.pone.00265752-s2.0-80054838951LangK. S.RollB.MyssinaS.SchittenhelmM.Scheel-WalterH.-G.KanzL.FritzJ.LangF.HuberS.WiederT.Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency2002125-636537210.1159/0000679072-s2.0-0036432879AyiK.TurriniF.PigaA.AreseP.Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait2004104103364337110.1182/blood-2003-11-38202-s2.0-8644226200de JongK.EmersonR. K.ButlerJ.BastackyJ.MohandasN.KuypersF. A.Short survival of phosphatidylserine-exposing red blood cells in murine sickle cell anemia20019851577158410.1182/blood.v98.5.15772-s2.0-0035469888KeanL. S.BrownL. E.NicholsJ. W.MohandasN.ArcherD. R.HsuL. L.Comparison of mechanisms of anemia in mice with sickle cell disease and beta-thalassemia: peripheral destruction, ineffective erythropoiesis, and phospholipid scramblase-mediated phosphatidylserine exposure200230539440210.1016/s0301-472x(02)00780-42-s2.0-0036265634BrowningJ. A.RobinsonH. C.ElloryJ. C.GibsonJ. S.Deoxygenation-induced non-electrolyte pathway in red cells from sickle cell patients2007191–416517410.1159/0000992042-s2.0-33847026927WoodB. L.GibsonD. F.TaitJ. F.Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations1996885187318802-s2.0-0029817966ChadebechP.HabibiA.NzouakouR.BachirD.Meunier-CostesN.BoninP.RodetM.ChamiB.GalacterosF.BierlingP.Noizat-PirenneF.Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death20094991785179210.1111/j.1537-2995.2009.02199.x2-s2.0-69249169929KuypersF. A.YuanJ.LewisR. A.SnyderL. M.KieferC. R.BunyaratvejA.FucharoenS.MaL.StylesL.De JongK.SchrierS. L.Membrane phospholipid asymmetry in human thalassemia1998918304430512-s2.0-0032522948BasuS.BanerjeeD.ChandraS.ChakrabartiA.Eryptosis in hereditary spherocytosis and thalassemia: role of glycoconjugates2010277–97177222-s2.0-7865125972010.1007/s10719-009-9257-6CappadoroM.GiribaldiG.O'BrienE.TurriniF.MannuF.UlliersD.SimulaG.LuzzattoL.AreseP.Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency1998927252725342-s2.0-0032189018GanesanS.ChaurasiyaN. D.SahuR.WalkerL. A.TekwaniB. L.Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: evaluation of eryptotic pathway20122941546010.1016/j.tox.2012.01.0152-s2.0-84857798694BruceL. J.RobinsonH. C.GuizouarnH.BorgeseF.HarrisonP.KingM.-J.GoedeJ. S.ColesS. E.GoreD. M.LutzH. U.FicarellaR.LaytonD. M.IolasconA.ElloryJ. C.StewartG. W.Monovalent cation leaks in human red cells caused by single amino-acid substitutions in the transport domain of the band 3 chloride-bicarbonate exchanger, AE120053711125812632-s2.0-2764459383310.1038/ng1656WeberY. G.StorchA.WuttkeT. V.BrockmannK.KempfleJ.MaljevicS.MargariL.KammC.SchneiderS. A.HuberS. M.PekrunA.RoeblingR.SeebohmG.KokaS.LangC.KraftE.BlazevicD.Salvo-VargasA.FaulerM.MottaghyF. M.MünchauA.EdwardsM. J.PresicciA.MargariF.GasserT.LangF.BhatiaK. P.Lehmann-HornF.LercheH.GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak20081186215721682-s2.0-45749108564AbedM.BalasahebS.TowhidS. T.DanielC.AmannK.LangF.Adhesion of annexin 7 deficient erythrocytes to endothelial cells201382e5665010.1371/journal.pone.00566502-s2.0-84874275868FöllerM.FeilS.GhoreschiK.KokaS.GerlingA.ThunemannM.HofmannF.SchulerB.VogelJ.PichlerB.KasinathanR. S.NicolayJ. P.HuberS. M.LangF.FeilR.Anemia and splenomegaly in cGKI-deficient mice2008105186771677610.1073/pnas.07089401052-s2.0-44349160577AbedM.TowhidS. T.FegerM.SchmidtS.Kuro-oM.GawazM.LangF.Adhesion of klotho-deficient eryptotic erythrocytes to endothelial cells2013207348549310.1111/apha.120462-s2.0-84873750018KempeD. S.AckermannT. F.FischerS. S.KokaS.BoiniK. M.MahmudH.FöllerM.RosenblattK. P.Kuro-OM.LangF.Accelerated suicidal erythrocyte death in Klotho-deficient mice2009458350351210.1007/s00424-009-0636-42-s2.0-67649559522FöllerM.KasinathanR. S.KokaS.HuberS. M.SchulerB.VogelJ.GassmannM.LangF.Enhanced susceptibility to suicidal death of erythrocytes from transgenic mice overexpressing erythropoietin20072933R1127R113410.1152/ajpregu.00110.20072-s2.0-34548419227AkelA.WagnerC. A.KovacikovaJ.KasinathanR. S.KiedaischV.KokaS.AlperS. L.BernhardtI.WiederT.HuberS. M.LangF.Enhanced suicidal death of erythrocytes from gene-targeted mice lacking the Cl−/HCO3− exchanger AE120072925C1759C176710.1152/ajpcell.00158.2006BhavsarS. K.GuS.BobbalaD.LangF.Janus kinase 3 is expressed in erythrocytes, phosphorylated upon energy depletion and involved in the regulation of suicidal erythrocyte death201127554755610.1159/0003299562-s2.0-79959399182FöllerM.MahmudH.KokaS.LangF.Reduced Ca2+ entry and suicidal death of erythrocytes in PDK1 hypomorphic mice2008455593994910.1007/s00424-007-0336-x2-s2.0-37249031439MaellaroE.LeonciniS.MorettiD.Del BelloB.TanganelliI.De FeliceC.CiccoliL.Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients201350448949510.1007/s00592-011-0274-02-s2.0-84884907779MandalD.Baudin-CreuzaV.BhattacharyyaA.PathakS.DelaunayJ.KunduM.BasuJ.Caspase 3-mediated proteolysis of the N-terminal cytoplasmic domain of the human erythroid anion exchanger 1 (band 3)20032785252551525582-s2.0-034799307210.1074/jbc.m306914200BratosinD.EstaquierJ.PetitF.ArnoultD.QuatannensB.TissierJ.-P.SlomiannyC.SartiauxC.AlonsoC.HuartJ.-J.MontreuilJ.AmeisenJ. C.Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria2001812114311562-s2.0-003567461610.1038/sj.cdd.4400946MandalD.MoitraP. K.SahaS.BasuJ.Caspase 3 regulates phosphatidylserine externalization and phagocytosis of oxidatively stressed erythrocytes20025132-31841882-s2.0-003718116710.1016/s0014-5793(02)02294-9MatarreseP.StrafaceE.PietraforteD.GambardellaL.VonaR.MaccagliaA.MinettiM.MalorniW.Peroxynitrite induces senescence and apoptosis of red blood cells through the activation of aspartyl and cysteinyl proteases20051934164182-s2.0-1464442147810.1096/fj.04-2450fjeWeilM.JacobsonM. D.RaffM. C.Are caspases involved in the death of cells with a transcriptionally inactive nucleus? Sperm and chicken erythrocytes199811118270727152-s2.0-0031752746DasA.SmolenskiA.LohmannS. M.KukrejaR. C.Cyclic GMP-dependent protein kinase Iα attenuates necrosis and apoptosis following ischemia/reoxygenation in adult cardiomyocyte200628150386443865210.1074/jbc.M6061422002-s2.0-33845977750LiJ. R.BilliarT. R.The anti-apoptotic actions of nitric oxide in hepatocytes199961095295510.1038/sj.cdd.44005792-s2.0-0032708392Nagai-KusuharaA.NakamuraM.MukunoH.KanamoriA.NegiA.SeigelG. M.cAMP-responsive element binding protein mediates a cGMP/protein kinase G-deendent anti-apoptotic signal induced by nitric oxide in retinal neuro-glial progenitor cells200784152162SchlossmannJ.FeilR.HofmannF.Insights into cGMP signalling derived from cGMP kinase knockout mice2005101279128910.2741/16182-s2.0-18944380695OwusuB. Y.StapleyR.PatelR. P.Nitric oxide formation versus scavenging: the red blood cell balancing act201259020499350002-s2.0-8486748491410.1113/jphysiol.2012.234906KahnM. J.MaleyJ. H.LaskerG. F.KadowitzP. J.Updated role of nitric oxide in disorders of erythrocyte function2013131838710.2174/1871529x113130100092-s2.0-84876696470GowA. J.LuchsingerB. P.PawloskiJ. R.SingelD. J.StamlerJ. S.The oxyhemoglobin reaction of nitric oxide199996169027903210.1073/pnas.96.16.90272-s2.0-0033529903MalanD.LeviR. C.AlloattiG.MarcantoniA.BedendiI.GalloM. P.Cyclic AMP and cyclic GMP independent stimulation of ventricular calcium current by peroxynitrite donors in guinea pig myocytes2003197228429610.1002/jcp.103682-s2.0-0242348817WilliamM.VienJ.HamiltonE.GarciaA.BundgaardH.ClarkeR. J.RasmussenH. H.The nitric oxide donor sodium nitroprusside stimulates the Na+-K+ pump in isolated rabbit cardiac myocytes200556538158252-s2.0-2134444614210.1113/jphysiol.2005.086447DimmelerS.HaendelerJ.NehlsM.ZeiherA. M.Suppression of apoptosis by nitric oxide via inhibition of interleukin- 1β-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases1997185460160710.1084/jem.185.4.6012-s2.0-0031037180RössigL.FichtlschererB.BreitschopfK.HaendelerJ.ZeiherA. M.MülschA.DimmelerS.Nitric oxide inhibits caspase-3 by S-nitrosation in vivo1999274116823682610.1074/jbc.274.11.68232-s2.0-0345291185BenharM.StamlerJ. S.A central role for S-nitrosylation in apoptosis20057764564610.1038/ncb0705-6452-s2.0-22144444152HaendelerJ.HoffmannJ.TischlerV.BerkB. C.ZeiherA. M.DimmelerS.Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 6920024107437492-s2.0-003679885610.1038/ncb851HaendelerJ.HoffmannJ.ZeiherA. M.DimmelerS.Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins2004110785686110.1161/01.cir.0000138743.09012.932-s2.0-4143102291HoffmannJ.HaendelerJ.ZeiherA. M.DimmelerS.TNF alpha and oxLDL reduce protein S-nitrosylation in endothelial cells200127644413834138710.1074/jbc.m1075662002-s2.0-0035798544MelinoG.BernassolaF.KnightR. A.CorasanitiM. T.NisticòG.Finazzi-AgròA.S-nitrosylation regulates apoptosis1997388664143243310.1038/412372-s2.0-0030855085CastilloS. S.LevyM.WangC.ThaikoottathilJ. V.KhanE.GoldkornT.Nitric oxide-enhanced caspase-3 and acidic sphingomyelinase interaction: a novel mechanism by which airway epithelial cells escape ceramide-induced apoptosis2007313481682310.1016/j.yexcr.2006.12.0012-s2.0-33846691177DavidsonS. M.DuchenM. R.Endothelial mitochondria: contributing to vascular function and disease20071008112811412-s2.0-3424759885610.1161/01.res.0000261970.18328.1dPacherP.BeckmanJ. S.LiaudetL.Nitric oxide and peroxynitrite in health and disease200787131542410.1152/physrev.00029.20062-s2.0-33846863589DasguptaT.FabryM. E.KaulD. K.Antisickling property of fetal hemoglobin enhances nitric oxide bioavailability and ameliorates organ oxidative stress in transgenic-knockout sickle mice20102982R394R40210.1152/ajpregu.00611.20092-s2.0-75449108995SalhanyJ. M.The oxidative denitrosylation mechanism and nitric oxide release from human fetal and adult hemoglobin, an experimentally based model simulation study201350181910.1016/j.bcmd.2012.08.0062-s2.0-84869870660KaulD. K.LiuX.-D.ChangH.-Y.NagelR. L.FabryM. E.Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice200411481136114510.1172/JCI2004216332-s2.0-9644260566BorstO.AbedM.AlesutanI.TowhidS. T.QadriS. M.FöllerM.GawazM.LangF.Dynamic adhesion of eryptotic erythrocytes to endothelial cells via CXCL16/SR-PSOX20123024C644C65110.1152/ajpcell.00340.20112-s2.0-84856573258BetalS. G.SettyB. N. Y.Phosphatidylserine-positive erythrocytes bind to immobilized and soluble thrombospondin-1 via its heparin-binding domain2008152416517710.1016/j.trsl.2008.07.0072-s2.0-54549115945ManodoriA. B.BarabinoG. A.LubinB. H.KuypersF. A.Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin2000954129313002-s2.0-0343339958FadokV. A.BrattonD. L.RoseD. M.PearsonA.EzekewitzR. A. B.HensonP. M.A receptor for phosphatidylserine-specific clearance of apoptotic cells20004056782859010.1038/350110842-s2.0-0034604029WalkerB.TowhidS. T.SchmidE.HoffmannS. M.AbedM.MünzerP.VogelS.NeisF.BruckerS.GawazM.BorstO.LangF.Dynamic adhesion of eryptotic erythrocytes to immobilized platelets via platelet phosphatidylserine receptors20143063C291C29710.1152/ajpcell.00318.20132-s2.0-84893407128AndrewsD. A.LowP. S.Role of red blood cells in thrombosis19996276822-s2.0-003281197810.1097/00062752-199903000-00004NagababuE.GulyaniS.EarleyC. J.CutlerR.MattsonM.RifkindJ.Iron-deficiency anaemia enhances red blood cell oxidative stress200842982482910.1080/107157608024598792-s2.0-57349103689QadriS. M.MahmudH.LangE.GuS.BobbalaD.ZelenakC.JilaniK.SiegfriedA.FöllerM.LangF.Enhanced suicidal erythrocyte death in mice carrying a loss-of-function mutation of the adenomatous polyposis coli gene20121651085109310.1111/j.1582-4934.2011.01387.x2-s2.0-84860348582Calderón-SalinasJ. V.Muñoz-ReyesE. G.Guerrero-RomeroJ. F.Rodríguez-MoránM.Bracho-RiquelmeR. L.Carrera-GraciaM. A.Quintanar-EscorzaM. A.Eryptosis and oxidative damage in type 2 diabetic mellitus patients with chronic kidney disease20113571-217117910.1007/s11010-011-0887-12-s2.0-84857435212ThornalleyP. J.Modification of the glyoxalase system in human red blood cells by glucose in vitro198825437517552-s2.0-0023778433NwoseE. U.JelinekH. F.RichardsR. S.KerrR. G.Erythrocyte oxidative stress in clinical management of diabetes and its cardiovascular complications200764135432-s2.0-34250784999BandeiraS. D. M.GuedesG. D. S.de FonsecaL. J. S.PiresA. S.GelainD. P.MoreiraJ. C. F.RabeloL. A.VasconcelosS. M. L.GoulartM. O. F.Characterization of blood oxidative stress in type 2 diabetes mellitus patients: increase in lipid peroxidation and SOD activity201220121381931010.1155/2012/8193102-s2.0-84870208571DmitrievaO.de LusignanS.MacdougallI. C.GallagherH.TomsonC.HarrisK.DesombreT.GoldsmithD.Association of anaemia in primary care patients with chronic kidney disease: cross sectional study of quality improvement in chronic kidney disease (QICKD) trial data201314, article 2410.1186/1471-2369-14-242-s2.0-84872762492YangM.FoxC. H.VassalottiJ.ChoiM.Complications of progression of CKD201118640040510.1053/j.ackd.2011.10.0012-s2.0-81255197659AdamsonJ. W.Hyporesponsiveness to erythropoiesis stimulating agents in chronic kidney disease: the many faces of inflammation2009162768210.1053/j.ackd.2008.12.0092-s2.0-60149109965AtkinsonM. A.FurthS. L.Anemia in children with chronic kidney disease201171163564110.1038/nrneph.2011.1152-s2.0-80255137113AttanasioP.RoncoC.AnkerS. D.CicoiraM.von HaehlingS.Role of iron deficiency and anemia in cardio-renal syndromes201232157622-s2.0-8485743884910.1016/j.semnephrol.2011.11.008BesarabA.CoyneD. W.Iron supplementation to treat anemia in patients with chronic kidney disease201061269971010.1038/nrneph.2010.1392-s2.0-79955024469KovesdyC. P.Iron and clinical outcomes in dialysis and non-dialysis-dependent chronic kidney disease patients200916210911610.1053/j.ackd.2008.12.0062-s2.0-60149092184KwackC.BalakrishnanV. S.Managing erythropoietin hyporesponsiveness200619214615110.1111/j.1525-139X.2006.00141.x2-s2.0-33645292037VosF. E.SchollumJ. B.CoulterC. V.DoyleT. C. A.DuffullS. B.WalkerR. J.Red blood cell survival in long-term dialysis patients201158459159810.1053/j.ajkd.2011.03.0312-s2.0-80053050709AntonelouM. H.KriebardisA. G.VelentzasA. D.KokkalisA. C.GeorgakopoulouS.-C.PapassideriI. S.Oxidative stress-associated shape transformation and membrane proteome remodeling in erythrocytes of end stage renal disease patients on hemodialysis20117411244124522-s2.0-8005485337410.1016/j.jprot.2011.04.009ZhuQ.SunZ.JiangY.ChenF.WangM.Acrolein scavengers: reactivity, mechanism and impact on health20115591375139010.1002/mnfr.2011001492-s2.0-80052525395FacorroG.AguirreF.FlorentinL.DíazM.De PaoliT.IhloJ. E.HagerA. A.Sánchez AvalosJ. C.FarachH. A.PooleC. P.Jr.Oxidative stress and membrane fluidity in erythrocytes from patients with hemolytic uremic syndrome19974731371462-s2.0-0030625599GomezS. A.Abrey-RecaldeM. J.PanekC. A.FerrarottiN. F.RepettoM. G.MejíasM. P.FernándezG. C.VanzulliS.IsturizM. A.PalermoM. S.The oxidative stress induced in vivo by Shiga toxin-2 contributes to the pathogenicity of haemolytic uraemic syndrome2013173346347210.1111/cei.121242-s2.0-84881495259GalleyH. F.Oxidative stress and mitochondrial dysfunction in sepsis20111071576410.1093/bja/aer0932-s2.0-79959412738GitlinJ. D.Wilson Disease200312561868187710.1053/j.gastro.2003.05.0102-s2.0-0345059398AttriS.SharmaN.JahagirdarS.ThapaB. R.PrasadR.Erythrocyte metabolism and antioxidant status of patients with wilson disease with hemolytic anemia200659459359710.1203/01.pdr.0000203098.77573.392-s2.0-33646708274NagasakaH.InoueI.InuiA.KomatsuH.SogoT.MurayamaK.MurakamiT.YorifujiT.AsayamaK.KatayamaS.UemotoS.KobayashiK.TakayanagiM.FujisawaT.TsukaharaH.Relationship between oxidative stress and antioxidant systems in the liver of patients with Wilson disease: hepatic manifestation in wilson disease as a consequence of augmented oxidative stress200660447247710.1203/01.pdr.0000238341.12229.d32-s2.0-33748893007LangP. A.KasinathanR. S.BrandV. B.DurantonC.LangC.KokaS.ShumilinaE.KempeD. S.TanneurV.AkelA.LangK. S.FöllerM.KunJ. F. J.KremsnerP. G.WesselborgS.LauferS.ClemenC. S.HerrC.NoegelA. A.WiederT.GulbinsE.LangF.HuberS. M.Accelerated clearance of Plasmodium-infected erythrocytes in sickle cell trait and annexin-A7 deficiency2009245-641542810.1159/0002575292-s2.0-70450257793BasuS.BanerjeeD.ChandraS.ChakrabartiA.Loss of phospholipid membrane asymmetry and sialylated glycoconjugates from erythrocyte surface in haemoglobin E β-thalassaemia20081411929910.1111/j.1365-2141.2008.06995.x2-s2.0-40449120184HaynesJ.Jr.ObiakoB.KingJ. A.HesterR. B.Ofori-AcquahS.Activated neutrophil-mediated sickle red blood cell adhesion to lung vascular endothelium: role of phosphatidylserine-exposed sickle red blood cells20062914H1679H168510.1152/ajpheart.00256.20062-s2.0-33749348212KaulD. K.TsaiH. M.LiuX. D.NakadaM. T.NagelR. L.CollerB. S.Monoclonal antibodies to alpha V beta 3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor20009523683742-s2.0-0034649782KumarA.EckmanJ. R.WickT. M.Inhibition of plasma-mediated adherence of sickle erythrocytes to microvascular endothelium by conformationally constrained RGD-containing peptides1996532929810.1002/(sici)1096-8652(199610)53:260;92::aid-ajh662;3.3.co;2-9SettyB. N. Y.KulkarniS.StuartM. J.Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion20029951564157110.1182/blood.v99.5.15642-s2.0-0036493303HaynesJ.ObiakoB.HesterR. B.BaligaB. S.StevensT.Hydroxyurea attenuates activated neutrophil-mediated sickle erythrocyte membrane phosphatidylserine exposure and adhesion to pulmonary vascular endothelium20082941H379H38510.1152/ajpheart.01068.20072-s2.0-38149032285HilleryC. A.DuM. C.WangW. C.ScottJ. P.Hydroxyurea therapy decreases the in vitro adhesion of sickle erythrocytes to thrombospondin and laminin2000109232232710.1046/j.1365-2141.2000.02040.x2-s2.0-0034082976SettyB. N. Y.KulkarniS.DampierC. D.StuartM. J.Fetal hemoglobin in sickle cell anemia: relationship to erythrocyte adhesion markers and adhesion20019792568257310.1182/blood.v97.9.25682-s2.0-0035353182YasinZ.WittingS.PalascakM. B.JoinerC. H.RucknagelD. L.FrancoR. S.Phosphatidylserine externalization in sickle red blood cells: associations with cell age, density, and hemoglobin F200310213653702-s2.0-003790209110.1182/blood-2002-11-3416CharacheS.TerrinM. L.MooreR. D.DoverG. J.BartonF. B.EckertS. V.McmahonR. P.BondsD. R.Effect of hydroxyurea on the frequency of painful crises in sickle-cell-anemia1995332201317132210.1056/nejm1995051833220012-s2.0-0029025475KirkK.Membrane transport in the malaria-infected erythrocyte20018124955372-s2.0-0035069258DurantonC.HuberS. M.TanneurV.LangK. S.BrandV. B.SanduC. D.LangF.Electrophysiological properties of the Plasmodium falciparum-induced cation conductance of human erythrocytes200313418919810.1159/0000724212-s2.0-0042665846BrandV. B.SanduC. D.DurantonC.TanneurV.LangK. S.HuberS. M.LangF.Dependence of Plasmodium falciparum in vitro growth on the cation permeability of the human host erythrocyte200313634735610.1159/0000751222-s2.0-0344826477LangF.LangP. A.LangK. S.BrandV.TanneurV.DurantonC.WiederT.HuberS. M.Channel-induced apoptosis of infected host cells—the case of malaria2004448331932410.1007/s00424-004-1254-92-s2.0-16544376141HuberS. M.DurantonC.LangF.Patch-clamp analysis of the ‘new permeability pathways’ in malaria-infected erythrocytes20052465913410.1016/s0074-7696(05)46003-92-s2.0-25144492753LewV. L.TiffertT.GinsburgH.Excess hemoglobin digestion and the osmotic stability of Plasmodium falciparum-infected red blood cells2003101104189419410.1182/blood-2002-08-26542-s2.0-0037589002JoshiP.GuptaC. M.Abnormal membrane phospholipid organization in Plasmodium falciparum-infected human erythrocytes19886822552592-s2.0-002385261310.1111/j.1365-2141.1988.tb06198.xSchwartzR. S.OlsonJ. A.Raventos-SuarezC.YeeM.HeathR. H.LubinB.NagelR. L.Altered plasma membrane phospholipid organization in Plasmodium falciparum-infected human erythrocytes19876924014072-s2.0-0023094768AyiK.GiribaldiG.SkorokhodA.SchwarzerE.PrendergastP. T.AreseP.16alpha-bromoepiandrosterone, an antimalarial analogue of the hormone dehydroepiandrosterone, enhances phagocytosis of ring stage parasitized erythrocytes: a novel mechanism for antimalarial activity200246103180318410.1128/aac.46.10.3180-3184.20022-s2.0-0036771811TurriniF.GinsburgH.BussolinoF.PescarmonaG. P.SerraM. V.AreseP.Phagocytosis of Plasmodium falciparum-infected human red blood cells by human monocytes: involvement of immune and nonimmune determinants and dependence on parasite developmental stage19928038018082-s2.0-0026688902ShermanI. W.EdaS.WinogradE.Erythrocyte aging and malaria20045021591692-s2.0-5444260179ShermanI. W.EdaS.WinogradE.Cytoadherence and sequestration in Plasmodium falciparum: defining the ties that bind20035108979092-s2.0-004206366610.1016/s1286-4579(03)00162-xKokaS.FöllerM.LamprechtG.BoiniK. M.LangC.HuberS. M.LangF.Iron deficiency influences the course of malaria in Plasmodium berghei infected mice200735736086142-s2.0-3424747293610.1016/j.bbrc.2007.03.175KokaS.HuberS. M.BoiniK. M.LangC.FöllerM.LangF.Lead decreases parasitemia and enhances survival of Plasmodium berghei-infected mice2007363348448910.1016/j.bbrc.2007.08.1732-s2.0-34848854504